Covid-19: India bans exports of Trump-backed drug as demand surges


(BLOOMBERG): India’s government has banned exports of hydroxychloroquine as global demand surges for the malaria drug touted by US President Donald Trump as a potential Covid-19 treatment.

Exports will be limited to fulfilling existing contracts, while certain shipments on humanitarian grounds may also be allowed on a case-by-case basis, according to a statement issued Wednesday by the Directorate General of Foreign Trade.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Russia's claim of emissions in annexed Ukraine regions draws protests at COP29
World leaders split as ICC issues arrest warrant for Netanyahu
Woman wins civil damages claim against MMA star Conor McGregor over rape accusation
North Korea condemns US military drills with South Korea and Japan
Trump taps Scott Bessent for Treasury, capping long drama over choice
Disabled Americans rely on rideshare apps but say they still face discrimination: AP
U.S. private-sector activity picks up pace as firms look forward to new gov't: survey
NYC congestion pricing plan to start in January
Spain's solar power poised to surpass wind power as top renewable energy source
U.S. stocks close higher

Others Also Read